• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受父亲扩展携带者筛查的障碍:筛查还是不筛查?

Perceived barriers to paternal expanded carrier screening following a positive maternal result: To screen or not to screen.

机构信息

Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA.

Cleveland Clinic Foundation, Genomic Medicine Institute, Cleveland, OH, USA.

出版信息

J Genet Couns. 2021 Apr;30(2):470-477. doi: 10.1002/jgc4.1333. Epub 2020 Oct 3.

DOI:10.1002/jgc4.1333
PMID:33010192
Abstract

Expanded carrier screening identifies individuals who are at risk of having a child with an autosomal recessive condition. The most accurate risk assessment requires that both mother and father undergo carrier screening to determine whether they are carriers of the same autosomal recessive condition. A couple identified as carriers of the same condition has a 25% chance of having a child with that condition. However, the father does not always opt for carrier screening following a positive result in the mother. This study aimed to identify barriers that prevent the father from carrier screening after a positive finding in the mother. A total of 58 women participated in this study. All participants had undergone expanded carrier screening prior to the study and had met with a genetic counselor for a pre-test, informed consent session. Of the 58 women, 34 had partners who did not undergo screening and 24 had partners who did. Participants completed a survey to determine the barriers that prevented the father of the baby's participation. We report that the mother's insurance type, whether the father has insurance, relationship status, and knowledge of the carrier screen showed statistically significant differences between women whose partners underwent screening and those that did not. In summary, our finding suggests that increasing insurance coverage of paternal screening and improving the patient's knowledge of the expanded screen would encourage paternal screening.

摘要

扩展携带者筛查可识别出有生育常染色体隐性疾病患儿风险的个体。最准确的风险评估需要母亲和父亲都进行携带者筛查,以确定他们是否携带相同的常染色体隐性疾病。如果一对夫妇被确定为携带相同疾病,那么他们生育该疾病患儿的概率为 25%。然而,在母亲的检测结果呈阳性后,父亲并不总是选择进行携带者筛查。本研究旨在确定在母亲的阳性检测结果后阻碍父亲进行携带者筛查的障碍。共有 58 名女性参与了这项研究。所有参与者在研究前都进行了扩展携带者筛查,并在预测试和知情同意会议上与遗传咨询师会面。在 58 名女性中,有 34 名女性的伴侣未进行筛查,24 名女性的伴侣进行了筛查。参与者完成了一份调查问卷,以确定阻止婴儿父亲参与的障碍。我们报告称,母亲的保险类型、父亲是否有保险、关系状况和对携带者筛查的了解在接受筛查和未接受筛查的女性之间存在统计学显著差异。总之,我们的研究结果表明,增加对父亲筛查的保险覆盖范围并提高患者对扩展筛查的了解,将鼓励父亲进行筛查。

相似文献

1
Perceived barriers to paternal expanded carrier screening following a positive maternal result: To screen or not to screen.接受父亲扩展携带者筛查的障碍:筛查还是不筛查?
J Genet Couns. 2021 Apr;30(2):470-477. doi: 10.1002/jgc4.1333. Epub 2020 Oct 3.
2
Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.扩展性携带者筛查:当夫妇中一方被确定为携带者时,经济负担和决策因素
J Assist Reprod Genet. 2021 Apr;38(4):957-963. doi: 10.1007/s10815-021-02084-6. Epub 2021 Jan 27.
3
The Use of Expanded Carrier Screening in Reproductive Medicine: Scientific Impact Paper No. 74.扩展携带者筛查在生殖医学中的应用:科学影响论文第 74 号。
BJOG. 2024 Sep;131(10):e81-e85. doi: 10.1111/1471-0528.17832. Epub 2024 Jun 5.
4
Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.加拿大妇产科医师学会(SOGC)和加拿大医学遗传学会(CCMG)关于生殖遗传携带者筛查的联合意见:面向直接面向消费者检测时代所有加拿大孕产妇和生殖健康护理提供者的最新信息。
J Obstet Gynaecol Can. 2016 Aug;38(8):742-762.e3. doi: 10.1016/j.jogc.2016.06.008.
5
Attitudes of the general population towards preconception expanded carrier screening for autosomal recessive disorders including inborn errors of metabolism.一般公众对常染色体隐性疾病(包括先天性代谢缺陷)的扩展性携带者筛查的态度。
Mol Genet Metab. 2019 Jan;126(1):14-22. doi: 10.1016/j.ymgme.2018.12.004. Epub 2018 Dec 10.
6
Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors.扩展携带者筛查用于生殖风险评估:来自国家遗传咨询师协会的循证实践指南。
J Genet Couns. 2023 Jun;32(3):540-557. doi: 10.1002/jgc4.1676. Epub 2023 Feb 9.
7
Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.囊性纤维化的遗传咨询与新生儿筛查:沟通流程评估
Pediatrics. 2001 Apr;107(4):699-705. doi: 10.1542/peds.107.4.699.
8
Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial.产前筛查在初级保健中的血红蛋白病:一项队列研究和集群随机试验,为模拟模型提供信息。第一孕期血红蛋白病筛查(SHIFT)试验。
Health Technol Assess. 2010 Apr;14(20):1-160. doi: 10.3310/hta14200.
9
Interest in expanded carrier screening among individuals and couples in the general population: systematic review of the literature.一般人群中个体和夫妇对扩展携带者筛查的兴趣:文献系统评价。
Hum Reprod Update. 2020 Apr 15;26(3):335-355. doi: 10.1093/humupd/dmaa001.
10
Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population.体外受精和一般人群中管理生殖遗传风险的孕前扩展携带者筛查的临床有效性和实用性。
Hum Reprod. 2021 Jun 18;36(7):2050-2061. doi: 10.1093/humrep/deab087.

引用本文的文献

1
The completion of indicated paternal prenatal genetic and carrier testing at a public hospital in Los Angeles, California.在加利福尼亚州洛杉矶的一家公立医院完成指定的父亲产前基因检测和携带者检测。
Genet Med Open. 2023 Sep 1;1(1):100831. doi: 10.1016/j.gimo.2023.100831. eCollection 2023.
2
Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fy antigens.验证一种非侵入性的产前胎儿 RhD、C、c、E、K 和 Fy 抗原检测方法。
Sci Rep. 2023 Aug 7;13(1):12786. doi: 10.1038/s41598-023-39283-3.
3
Evaluating the efficacy of three carrier screening workflows designed to identify at-risk carrier couples.
评估三种旨在识别高危携带者夫妇的载体筛查工作流程的效果。
Prenat Diagn. 2021 Jun;41(7):896-904. doi: 10.1002/pd.5900. Epub 2021 Feb 8.